Kirsten G. M. Aspros

Also affiliated with WinnMed, Mayo Clinic in Arizona

Biochemistry, Genetics and Molecular BiologyMedicineChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer”.

Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer

npj Breast Cancer(2022)10.1038/s41523-022-00387-0

N/A

0DataRank · unranked

18 citations

Jodi M. Carter, Tanya L. Hoskin, Vera J. Suman, Malayannan Subramaniam, Michael J. Emch +22 more

Estrogen-regulated miRs in bone enhance osteoblast differentiation and matrix mineralization

Molecular Therapy — Nucleic Acids(2023)10.1016/j.omtn.2023.05.026

N/A

0DataRank · unranked

7 citations

Zofia Wicik, Kirsten G. M. Aspros, Tanja Vukajlovic, Kevin S. Pitel, Anders K. Narum +9 more

Disruption of estrogen receptor beta’s DNA binding domain impairs its tumor suppressive effects in triple negative breast cancer

Frontiers in Medicine(2023)10.3389/fmed.2023.1047166

N/A

0DataRank · unranked

6 citations

Michael J. Emch, Xiyin Wang, Malayannan Subramaniam, Megan L. Hinkle, Esther Rodman +3 more